A decline in the efficacy of hyposensitization due to the adverse effects of antitubercular agents against a background of immuno-correction
Prosvetov, I.V.; Spesivtsev, O.G.; Gal'chanskaia, L.D.
Problemy Tuberkuleza 1990(11): 54-55
1990
ISSN/ISBN: 0032-9533 PMID: 2290819 Document Number: 362381
Document emailed within 1 workday
Related Documents
Waisser, K.; Celadník, M.; Sova, J.; Palát, K. 1975: Antitubercular agents. XVI. use of HMO computations in the study of structure-activity relationship of antitubercular agents. IIi Ceskoslovenska Farmacie 24(10): 423-426Katikova, O.I.; Kostin, I.V. 2002: Efficacy of galstena in liver damage induced by antitubercular agents Eksperimental'naia i Klinicheskaia Farmakologiia 65(2): 64-66
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Sorbette, F.; Conte, S.; Montastruc, J.L. 1992: Role of adverse effects of immuno-allergic nature at a Regional Pharmacovigilance Center Therapie 47(5): 445-446
Decocq, G.; Compagnon, M.; Andréjak, M.; Guedj, B.; Doutrellot, C. 1996: Adverse effects related to the use of antitubercular drugs in psychiatric centers: retrospective study at the Philippe Pinel CH in Amiens 1994 Therapie 51(5): 543-549
Khomenko, A.G.; Shmelev, N.A.; Stepanian, E.S.; Priss, I.S.; Koviazina, A.I. 1976: Side effects of antitubercular agents and current methods of detection of drug allergy in chemotherapy of tuberculosis Problemy Tuberkuleza 3: 18-24
Valueva, L.N.; Tozhanova, N.M. 1982: Sidnocarb correction of the adverse effects of benzodiazepine tranquilizers Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 82(8): 92-97
Waisser, K.; Dolezal, M.; Sidóová, E.; Odlerová, Z.; Drsata, J. 1988: Biological side-effects of potential anti-tubercular agents. XIV. Relation between the chemical structure, antitubercular activity and hepatotoxicity of 2-alkylthio-6-(2-chlorobenzamido) benzothiazoles Ceskoslovenska Farmacie 37(10): 437-439
Saito, A.; Yamaji, T.; Saigusa, M. 1986: Adverse effects of antimicrobiological agents and countermeasures--TDM and countermeasures against adverse effects Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 955-958
Fukuchi, S.; Yoshida, Y.; Yamada, N.; Hayakawa, K.; Hashimoto, M.; Ueda, O.; Ito, K.; Hoshihara, Y. 1984: Efficacy of anti-ulcer agents judged from background factors of stomach ulcer Nihon Rinsho. Japanese Journal of Clinical Medicine 42(1): 144-149
Horák, O. 1970: Adverse effects of hypotensive agents Casopis Lekaru Ceskych 109(41): 969-972
Hillestad, L. 1972: Adverse effects and complications with antiarrhythmic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(5): 343-345
Semb, K.A.; Jakobsen, E. 2003: Cardiovascular adverse effects of cytostatic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(1): 44-45
Hitzenberger, G. 1971: Dosage and adverse effects in the use of antihypertensive and diuretic agents Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 5(3): 309-314
Menkes, D.B.; Wood, K.; Wooods, D. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 476
Fahy, T.J. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 475-476
Pavelka, K. 1985: Prevention of adverse side-effects of nonsteroidal antirheumatic agents Vnitrni Lekarstvi 31(7): 706-710
Gol'dovskaia, I.L. 1990: Prevention and correction of the side effects of psychopharmacologic agents on the eye Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(2): 90-94
Domingo, J.L. 1995: Adverse effects of potential agents for the treatment of Alzheimer's disease: a review Adverse Drug Reactions and Toxicological Reviews 14(2): 101-115
Graves, D.; Cocohoba, J.; Gruta, C.; Goldschmidt, R. 2004: Potential adverse effects and inferior efficacy in ARV treatment Journal of the National Medical Association 96(5): 692